Share on LinkedInShare on LinkedIn

ARTICLE · 12 AUGUST 2024

AI-Powered Medical Devices Bring Patent And Regulatory Pitfalls

WilmerHale
WilmerHale
Contributor
WilmerHale

WilmerHale

WilmerHale's London office was established more than 40 years ago. With lawyers qualified in the...

View firm profile
Explore more from WilmerHale

Artificial intelligence and machine learning are transforming the medical device industry. Simultaneously, companies are working to gain Food and Drug Administration approval and obtain intellectual property protection...

United StatesIntellectual Property

In an article published in Bloomberg Law, Partner Alexis Cohen, Senior Associate Gilbert Smolenski and Associate Xanadu Halkias explain the potential challenges facing developers of AI-powered medical devices and discuss the risks to IP protection efforts when disclosing too much to the FDA.

Excerpt: "Recognizing that technological advances can happen more quickly than the regulatory approval process allows—including in real time for dynamic or self-taught models—the FDA and Congress have been working toward a new regulatory framework that attempts to account for such advances."

Read the full article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from